Nontuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors and impact on survival and chronic lung allograft dysfunction.

PubMed Articles [27404 Associated PubMed Articles listed on BioPortfolio]

Multidrug-resistant Acinetobacter baumannii infection in lung transplant recipients: risk factors and prognosis.

Infectious complication is an important cause of poor outcome of lung transplantation (LT). Infections with Acinetobacter baumannii (A. baumannii) are problematic, because of limited therapeutic optio...

Discharge frailty following lung transplantation.

Frailty at listing for lung transplant has been associated with waitlist and post-transplant mortality. Frailty trajectories following transplant, however, have been less well characterized, including...

Hepatitis E seroprevalence and associated risk factors in Croatian liver transplant recipients.

Solid-organ transplant recipients are at risk of hepatitis E virus (HEV) infection. We analyzed the seroprevalence/risk factors of HEV in Croatian liver transplant recipients.

Prevalence of Frailty among Kidney Transplant Candidates and Recipients in the United States: Estimates from a National Registry and Multi-center Cohort Study.

Frailty, a measure of physiologic reserve, is associated with poor outcomes and mortality among kidney transplant (KT) candidates and recipients. There are no national estimates of frailty in this pop...

Nontuberculous Mycobacteria, Botswana, 2011-2014.

We documented a 6-fold increase in the frequency of nontuberculous mycobacteria isolated from clinical samples in Botswana during 2011-2014. Because antituberculosis treatment is often initiated only ...

Clinical Trials [18950 Associated Clinical Trials listed on BioPortfolio]

Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria

Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease

A prospective, single-center, open-label study involving patients with refractory nontuberculous mycobacteria lung disease to ascertain pharmacokinetics, safety, efficacy, and tolerability...

Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also ...

A Registry for Nontuberculous Mycobacterial Pulmonary Disease

Background: NTM(Nontuberculous mycobacteria) pulmonary disease is increasing worldwidely, however the diagnosis and treatment of NTM pulmonary disease still has multiple obstacles. The in...

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

This is a single arm, open-label interventional study of ingenol mebutate 0.015% in solid organ transplant recipients. The investigators plan to treat 20 subjects, 10 kidney transplant rec...

Medical and Biotech [MESH] Definitions